INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community
Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug discovery for priority viruses of pandemic and endemic concern CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- The INTREPID Alliance today announced the launch of the Antiviral Toolbox, an open-access resource to support the global research community in its efforts toward filling...
Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel
Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health and Multiomics Research MORRISVILLE, N.C., Nov. 4, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced that Metabolon's Global...
IMG Announces Winner of First Student Journey Scholarship
INDIANAPOLIS, Nov. 4, 2025 /PRNewswire/ -- IMG (International Medical Group) is excited to announce Susana Yeboah, a freshman nursing student at East Tennessee State University, as the winner of its inaugural Student Journey Scholarship. Launched earlier this year, the Student Journey Scholarship is designed to support international students pursuing higher education in the...
Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801
BEIJING, Nov. 4, 2025 /PRNewswire/ -- Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation immunotherapies, today announced that its groundbreaking GT801 in vivo CAR-T program has been selected for an oral presentation at the upcoming 67th American Society of Hematology (ASH) Annual Meeting, to be held December...
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
BEIJING, Nov. 4, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has entered into an Agreement and Plan of Merger (the "Merger Agreement")...
Sky Labs Attracts Investment With Omron Subsidiary ‘OMRON VENTURES’
Global blood pressure monitoring No. 1 OMRON Healthcare signs strategic partnership MoU SEOUL, South Korea, Nov. 4, 2025 /PRNewswire/ -- On November 4, 2025, Sky Labs announced that it had attracted investments with OMRON Ventures(OVC: Minato-ku, Tokyo), Omron Group's enterprise-led venture capital (CVC). This means strengthening strategic partnerships for global business expansion beyond simple...
Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA
Company Leverages Legacy of Trust and Expertise as it Makes Inaugural Appearance at COMPAMED/MEDICA BOSTON, Nov. 4, 2025 /PRNewswire/ -- Elevaris Medical Devices, the world-class Contract Development and Manufacturing Organization resulting from the acquisition of UK-based XL Precision Technologies by U.S.-based Spectra Medical Devices, is introducing its services and procedural needle portfolio...
The 5th World Health Forum Highlights Climate Change as a Defining Public Health Challenge
BEIJING, Nov. 4, 2025 /PRNewswire/ -- The 5th World Health Forum convened in Beijing on November 1, gathering nearly 400 experts, scholars, and representatives from 22 countries and regions to explore new pathways for global health governance under the theme "Climate Change and Health: Responsibility, Governance and a Shared Future for Mankind." In his keynote address, Ban Ki-moon, Chairman...
NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa
Updated cancer treatment guidelines reflect significant progress in cancer care delivery through ongoing collaborative efforts to strengthen oncology resources across the region. HAMMAMET, Tunisia, Nov. 4, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—collaborated with the African Cancer Coalition and the American Cancer Society to describe how cancer treatment guidelines...
Hasten Sets a New Benchmark for Global Expansion by Building an End-to-End Asia-Pacific Healthcare Commercial Platform
SHANGHAI, Nov. 4, 2025 /PRNewswire/ -- Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced that while completing 70 Marketing Authorization Transfers (MAT) for its Asia-Pacific product portfolio, the company has established an end-to-end commercial network covering Southeast Asia, Australia, Korea, Hong Kong SAR and Taiwan, Province of China. This milestone marks Hasten successfully building a viable pan-Asia-Pacific commercial platform and...
